Tissue Repair Ltd (TRP.AX)
AUD 0.27
(0.0%)
AUD 0.27
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 214.72 Thousand AUD | 958.53% |
| 2023 | 20.28 Thousand AUD | -93.85% |
| 2022 | 329.83 Thousand AUD | -24.87% |
| 2021 | 439 Thousand AUD | 0.0% |
| 2020 | - AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 214.72 Thousand AUD | -14.87% |
| 2024 Q2 | 252.23 Thousand AUD | 0.0% |
| 2024 FY | 214.72 Thousand AUD | 958.53% |
| 2024 Q1 | 252.23 Thousand AUD | 1143.47% |
| 2024 Q4 | 214.72 Thousand AUD | 0.0% |
| 2023 Q1 | - AUD | 0.0% |
| 2023 FY | 20.28 Thousand AUD | -93.85% |
| 2023 Q3 | 20.28 Thousand AUD | 0.0% |
| 2023 Q4 | 20.28 Thousand AUD | 0.0% |
| 2023 Q2 | - AUD | 0.0% |
| 2022 Q1 | - AUD | 0.0% |
| 2022 FY | 329.83 Thousand AUD | -24.87% |
| 2022 Q4 | - AUD | 0.0% |
| 2022 Q3 | - AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2021 Q3 | - AUD | 0.0% |
| 2021 FY | 439 Thousand AUD | 0.0% |
| 2021 Q1 | - AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2020 FY | - AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 1.4 Million AUD | 84.676% |
| Anatara Lifesciences Ltd | -671.09 Thousand AUD | 131.996% |
| Zelira Therapeutics Limited | 1.25 Million AUD | 82.854% |
| Biome Australia Limited | 1.88 Million AUD | 88.63% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 1.17 Million AUD | 81.751% |
| Imugene Limited | - AUD | -Infinity% |
| Noxopharm Limited | -2.35 Million AUD | 109.101% |
| PYC Therapeutics Limited | -17.99 Million AUD | 101.193% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | - AUD | -Infinity% |
| Cynata Therapeutics Limited | 108.2 Thousand AUD | -98.442% |
| CSL Limited | 8.93 Billion AUD | 99.998% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 97.979% |
| Starpharma Holdings Limited | 2.4 Million AUD | 91.083% |
| Nanollose Limited | - AUD | -Infinity% |
| Memphasys Limited | 164.76 Thousand AUD | -30.323% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | 326.064% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | - AUD | -Infinity% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | 82.245% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | 124.477% |
| Race Oncology Limited | 16.4 Thousand AUD | -1209.201% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.31 Million AUD | 98.76% |
| Dimerix Limited | - AUD | -Infinity% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 2.00 AUD | -10736000.0% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 1.00 AUD | -21472100.0% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 147 Thousand AUD | -46.069% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | - AUD | -Infinity% |
| AdAlta Limited | -1.67 Million AUD | 112.785% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | 121.746% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 221.85 Thousand AUD | 3.216% |
| Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 97.11 Thousand AUD | -121.096% |
| Actinogen Medical Limited | 108.82 Thousand AUD | -97.302% |
| Immuron Limited | 1.58 Million AUD | 86.45% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |